Testing EPI-001 for male and female pattern hair loss
Part of Skin clinical trials.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have been diagnosed with androgenetic alopecia (pattern hair loss)
- You agree not to change your hairstyle, hair length, or hair color during the study
- You avoid other hair-growth products and procedures (like minoxidil or PRP) during the study
- You accept scalp tattooing marks and hair trimming for measurement photography
- You have not had a hair transplant, stem cell therapy, or gene therapy before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.
This trial compares different in-office procedures (like injections, lasers, or platelet-rich plasma) to treat male pattern hair loss. It aims to find which method works best to help hair grow back or stop thinning. Participation could provide access to new treatments that target the root cause of hair loss.
This study tests a new scalp product called DA-001 to see if it reduces hair shedding and helps hair grow back in people with telogen effluvium. It's a clinical trial that compares the treatment to a placebo (a product without the active ingredient) to find out if it works.
This Phase 3 study tests whether a specific hair lotion works and is safe for men with male pattern hair loss. It also checks that results are consistent while you keep similar hair care and avoid certain other hair-loss treatments.
This study tests two new topical treatments for hereditary hair loss. It may help you regrow hair or slow further thinning.
This trial compares two treatments—secretome and platelet-rich plasma (PRP)—to see which helps grow thicker, denser hair in people with genetic hair loss (androgenetic alopecia). It's for adults aged 25 to 59 who have stopped taking certain hair loss medications for at least a month.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.